• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一类新型潜在朊病毒药物:多层涂覆金纳米粒子的初步体外和体内数据。

A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles.

机构信息

Laboratory of Prion Biology, Neurobiology Sector, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Ed. Q1, Basovizza Campus, S.S.14 Km. 163,5, 34149, Trieste, Italy.

出版信息

Nanoscale. 2010 Dec;2(12):2724-32. doi: 10.1039/c0nr00551g. Epub 2010 Oct 14.

DOI:10.1039/c0nr00551g
PMID:20944860
Abstract

Gold nanoparticles coated with oppositely charged polyelectrolytes, such as polyallylamine hydrochloride and polystyrenesulfonate, were examined for potential inhibition of prion protein aggregation and prion (PrPSc) conversion and replication. Different coatings, finishing with a positive or negative layer, were tested, and different numbers of layers were investigated for their ability to interact and reduce the accumulation of PrPSc in scrapie prion infected ScGT1 and ScN2a cells. The particles efficiently hampered the accumulation of PrPSc in ScN2a cells and showed curing effects on ScGT1 cells with a nanoparticle concentration in the picomolar range. Finally, incubation periods of prion-infected mice treated with nanomolar concentrations of gold nanoparticles were significantly longer compared to untreated controls.

摘要

用带相反电荷的聚电解质(如盐酸多聚赖氨酸和聚苯乙烯磺酸钠)包覆的金纳米颗粒,被研究其是否可能抑制朊病毒蛋白聚集和朊病毒(PrPSc)转化和复制。用不同的涂层进行测试,完成带有正层或负层,研究不同数量的层的能力,以相互作用并减少朊病毒感染的 ScGT1 和 ScN2a 细胞中 PrPSc 的积累。这些颗粒有效地阻止了 ScN2a 细胞中 PrPSc 的积累,并对 ScGT1 细胞表现出治疗效果,纳米颗粒浓度在皮摩尔范围内。最后,用纳米颗粒浓度处理的感染朊病毒的小鼠的潜伏期与未处理的对照相比显著延长。

相似文献

1
A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles.一类新型潜在朊病毒药物:多层涂覆金纳米粒子的初步体外和体内数据。
Nanoscale. 2010 Dec;2(12):2724-32. doi: 10.1039/c0nr00551g. Epub 2010 Oct 14.
2
Living fungi cells encapsulated in polyelectrolyte shells doped with metal nanoparticles.包裹在掺杂金属纳米颗粒的聚电解质壳中的活真菌细胞。
Langmuir. 2009 Apr 21;25(8):4628-34. doi: 10.1021/la803871z.
3
Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study.功能化金纳米粒子:体内多模态显微镜脑分布的详细研究。
Nanoscale. 2010 Dec;2(12):2826-34. doi: 10.1039/c0nr00345j. Epub 2010 Oct 15.
4
Multilayer coating of gold nanoparticles with drug-polymer coadsorbates.载药聚合物共吸附剂的金纳米粒子多层包覆。
Langmuir. 2010 Nov 16;26(22):16901-8. doi: 10.1021/la103109b. Epub 2010 Oct 21.
5
Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.带电荷的双极苏拉明衍生物可诱导朊病毒蛋白在细胞表面聚集,并抑制PrPSc复制。
J Cell Sci. 2005 Nov 1;118(Pt 21):4959-73. doi: 10.1242/jcs.02609. Epub 2005 Oct 11.
6
Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells.
Biol Chem. 2000 May-Jun;381(5-6):463-9. doi: 10.1515/BC.2000.061.
7
The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity.芬顿反应对蛋白酶抗性朊病毒蛋白(PrPSc)降解及羊瘙痒病感染性的影响。
Brain Res. 2008 Oct 31;1238:172-80. doi: 10.1016/j.brainres.2008.07.117. Epub 2008 Aug 9.
8
Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies.工程金纳米粒子的生物分布和毒性:体外和体内研究综述。
Chem Soc Rev. 2011 Mar;40(3):1647-71. doi: 10.1039/c0cs00018c. Epub 2010 Nov 16.
9
Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.表位扫描揭示了与正常细胞朊病毒向瘙痒病朊病毒转化相关的毒株特异性抗体结合表位的获得与丧失。
J Neurochem. 2004 Sep;90(5):1205-17. doi: 10.1111/j.1471-4159.2004.02582.x.
10
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.慢病毒载体介导的RNA干扰有效地抑制朊病毒蛋白并延长瘙痒病感染小鼠的存活时间。
J Clin Invest. 2006 Dec;116(12):3204-10. doi: 10.1172/JCI29236.

引用本文的文献

1
Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy.纳米神经诊疗学:纳米颗粒对神经功能障碍的影响以及降低毒性以提高疗效的策略。
Front Pharmacol. 2021 Mar 26;12:612692. doi: 10.3389/fphar.2021.612692. eCollection 2021.
2
The Influence of Size and Chemical Composition of Silver and Gold Nanoparticles on in vivo Toxicity with Potential Applications to Central Nervous System Diseases.银和金纳米颗粒的尺寸和化学成分对体内毒性的影响及其在中枢神经系统疾病治疗中的潜在应用。
Int J Nanomedicine. 2021 Mar 15;16:2187-2201. doi: 10.2147/IJN.S260375. eCollection 2021.
3
Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process.
不同电荷修饰的超顺磁性纳米颗粒对α-突触核蛋白和β-淀粉样蛋白纤维形成过程的影响。
Int J Nanomedicine. 2019 Jan 23;14:799-808. doi: 10.2147/IJN.S190354. eCollection 2019.
4
Neurotheranostics as personalized medicines.神经治疗学作为个性化药物。
Adv Drug Deliv Rev. 2019 Aug;148:252-289. doi: 10.1016/j.addr.2018.10.011. Epub 2018 Oct 26.
5
Implications of peptide assemblies in amyloid diseases.肽组装体在淀粉样疾病中的意义。
Chem Soc Rev. 2017 Oct 30;46(21):6492-6531. doi: 10.1039/c7cs00372b.
6
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.神经分子成像,一种用于帕金森病的纳米生物技术:推进个性化医学的药物治疗
J Neural Transm (Vienna). 2017 Jan;124(1):57-78. doi: 10.1007/s00702-016-1633-3. Epub 2016 Oct 28.
7
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches.用于增强金纳米颗粒向脑部递送的肽和蛋白质:临床前研究方法。
Int J Nanomedicine. 2015 Aug 10;10:4919-36. doi: 10.2147/IJN.S82310. eCollection 2015.
8
Prion protein interaction with soil humic substances: environmental implications.朊病毒蛋白与土壤腐殖质的相互作用:对环境的影响
PLoS One. 2014 Jun 17;9(6):e100016. doi: 10.1371/journal.pone.0100016. eCollection 2014.
9
A novel expression system for production of soluble prion proteins in E. coli.一种在大肠杆菌中生产可溶性朊病毒蛋白的新型表达系统。
Microb Cell Fact. 2012 Jan 10;11:6. doi: 10.1186/1475-2859-11-6.